Thoracic oncology

Progression vs. pseudo progression in the treatment of squamous NSCLC with nivolumab
Stefan Rudiger, Cornelia Kropf-Sanchen, Gerlinde Schmidtke-Schrezenmeier, Marta Aksentiy, Katja Hoss, Wolfgang Rottbauer

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4845; DOI: 10.1183/13993003.congress-2016.PA4845
Checkpointinhibition in lung cancer – How to distinguish pseudoprogression from progressive disease
Achim Rittmeyer, Birgit Zwerger, Reinhardt Christian, Josef Rüschoff, Hans-Ulrich Schildhaus, Stefan Andreas

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4844; DOI: 10.1183/13993003.congress-2016.PA4844
Pemetrexed in maintenance therapy of 164 patients with advanced non-small-cell lung cancer (NSCLC)
Jana Skricková, Zbynek Bortlicek, Karel Hejduk, Milos Pesek, Vitezslav Kolek, Marcela Tomiskova, Ivona Grygarkova, Leona Koubkova, Marketa Cernovska, Jaromir Roubec, Frantisek Salajka, Milada Zemanova, Helena Coupkova, Monika Satankova, Milosalav Marel

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4839; DOI: 10.1183/13993003.congress-2016.PA4839
Should preoperative FDG uptake on PET/CT guide postoperative surveillance in surgical non-small cell lung cancer (NSCLC)
Emma Denneny, Sarah Clarke, Ravi Ragatha, Samir Naik, Peter Russell, Nick Panagiotopoulos, David Lawrence, Ugo Ekeowa

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4849; DOI: 10.1183/13993003.congress-2016.PA4849
Should CT-guided biopsy for suspected lung cancer be delayed pending PET/CT results?
Paul Griffiths, Joanne Heaton, Sarah Claxton

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4673; DOI: 10.1183/13993003.congress-2016.PA4673
Management of residual pleural space and persistent airleak after major lung resection
Kalliopi Athanassiadi, Ioannis Alevizakis, Nikolaos Papakonstantinou, Stamatios Kakaris

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4848; DOI: 10.1183/13993003.congress-2016.PA4848
Does consolidation chemotherapy improves survival for locally advanced non-small-cell lung cancer patients receiving concurrent chemoradiotherapy?
Berna Kömürcüoglu, Yelda Vatansever, Esra Korkmaz, Aysen Evkan, Enver Yalniz

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4843; DOI: 10.1183/13993003.congress-2016.PA4843
LATE-BREAKING ABSTRACT: Poor outcome following lung transplantation in CF patients infected with mycobacterium abscessus appears to be associated with two genetic clusters of mycobacterium abscessus subspecies abscessus
Ema Kavaliunaite, Kathryn A. Harris, Paul Aurora, Garth Dixon, Delane Shingadia, Nagarajan Muthialu, Helen Spencer

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4872; DOI: 10.1183/13993003.congress-2016.PA4872
Chemotherapy toxicity in advanced non-small cell lung cancer and its impact on survival
Hela Cherif, Saoussen Bacha, Sonia Habibech, Hager Racil, Sana Cheikhrouhou, Naouel Chaouech, Abdellatif Chabbou, Mohamed Lamine Megdiche

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4841; DOI: 10.1183/13993003.congress-2016.PA4841
Safety of a new “all in one” 3D device for fiducial tumor marking: A pilot animal study
Bruno Escarguel, Javier Flandes, Jean Baptiste Paoli, Olivier Monnet, Julien Legodec, Clément Fournier, Jean Michel Vergnon

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4674; DOI: 10.1183/13993003.congress-2016.PA4674

Main menu

User menu

Search

Thoracic oncology

Pages

Contact us